瑞普生物(300119)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300119 瑞普生物

已收盘 02-12 15:00:00

{"stockData":{"symbol":"300119","market":"SZ","secType":"STK","nameCN":"瑞普生物","latestPrice":19.11,"timestamp":1770879804000,"preClose":19.31,"halted":0,"volume":3597469,"delay":0,"changeRate":-0.0104,"floatShares":335000000,"shares":465000000,"eps":0.9001,"marketStatus":"已收盘","change":-0.2,"latestTime":"02-12 15:00:00","open":19.3,"high":19.3,"low":19.1,"amount":68933200,"amplitude":0.0104,"askPrice":19.12,"askSize":127,"bidPrice":19.11,"bidSize":250,"shortable":0,"etf":0,"ttmEps":0.9001,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770946200000},"marketStatusCode":5,"adr":0,"adjPreClose":19.31,"symbolType":"stock","openAndCloseTimeList":[[1770859800000,1770867000000],[1770872400000,1770879600000]],"highLimit":21.24,"lowLimit":17.38,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":464754706,"isCdr":false,"pbRate":1.92,"roa":"--","peRate":21.230974,"roe":"7.93%","epsLYR":0.6533,"committee":0.269674,"marketValue":8881000000,"turnoverRate":0.0107,"status":1,"floatMarketCap":6401000000},"requestUrl":"/m/hq/s/300119","defaultTab":"news","newsList":[{"id":"2608387332","title":"瑞普生物：截至2026年1月30日，公司股东总户数为26,214户","url":"https://stock-news.laohu8.com/highlight/detail?id=2608387332","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608387332?lang=zh_cn&edition=full","pubTime":"2026-02-04 09:06","pubTimestamp":1770167179,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物(300119)02月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问1月31日公司股东人数是多少？谢谢！瑞普生物回复：投资者您好，截至2026年1月30日，公司股东总户数为26,214户，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400007763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0046","300119","BK0239"],"gpt_icon":0},{"id":"2607032799","title":"股市必读：瑞普生物（300119）1月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2607032799","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607032799?lang=zh_cn&edition=full","pubTime":"2026-01-30 01:18","pubTimestamp":1769707092,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，瑞普生物报收于19.95元，下跌1.34%，换手率2.52%，成交量8.45万手，成交额1.69亿元。董秘最新回复投资者： 公司有尼帕病毒相关的检测业务或疫苗或药物吗董秘： 您好，公司目前无尼帕病毒相关的针对性疫苗、药品，将持续关注相关病毒动态，合理评估研发机会。敬请投资者注意投资风险，感谢您的关注！当日关注点来自交易信息汇总：1月29日主力资金净流出2894.79万元，显示主力资金明显离场。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000000766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK0046","300119"],"gpt_icon":0},{"id":"2606138297","title":"1月26日瑞普生物涨5.20%，华安创业板两年定开混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606138297","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606138297?lang=zh_cn&edition=full","pubTime":"2026-01-26 15:50","pubTimestamp":1769413854,"startTime":"0","endTime":"0","summary":"证券之星消息，1月26日瑞普生物涨5.20%，收盘报21.44元，换手率5.97%，成交量20.01万手，成交额4.22亿元。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为华安基金的华安创业板两年定开混合。华安创业板两年定开混合目前规模为1.86亿元，最新净值2.0706，较上一交易日上涨1.54%，近一年上涨68.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600015249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","159967","515890","000905.SH","BK0239","000688.SH","300119","000300.SH","BK0070","510300","399001","510880","512510","512880"],"gpt_icon":0},{"id":"2605463019","title":"瑞普生物：喵干素为重组猫干扰素ω","url":"https://stock-news.laohu8.com/highlight/detail?id=2605463019","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605463019?lang=zh_cn&edition=full","pubTime":"2026-01-22 15:54","pubTimestamp":1769068454,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物(300119)01月22日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，喵干素是合成生物制品吗？现在贵公司还有其他合成生物制品吗？谢谢！瑞普生物回复：投资者您好！喵干素为重组猫干扰素ω（冻干型），其主要成分为重组猫干扰素ω蛋白，主要用于猫疱疹病毒感染的治疗，可提升猫咪的抗感染能力，属于兽用生物制品。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200020380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0070","300119","BK0239"],"gpt_icon":0},{"id":"2605630364","title":"瑞普生物：截至2026年1月20日股东户数为25,567户","url":"https://stock-news.laohu8.com/highlight/detail?id=2605630364","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605630364?lang=zh_cn&edition=full","pubTime":"2026-01-22 15:54","pubTimestamp":1769068451,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物(300119)01月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年1月20日，公司股东人数是多少？瑞普生物回复：投资者您好，截至2026年1月20日，公司股东总户数为25,567户，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200020375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300119","BK0046","BK0239","BK0070"],"gpt_icon":0},{"id":"2605463045","title":"瑞普生物：已推出疫苗、驱虫药、保健品等二十余款宠物相关产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2605463045","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605463045?lang=zh_cn&edition=full","pubTime":"2026-01-22 15:54","pubTimestamp":1769068450,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物01月22日在投资者关系平台上答复投资者关心的问题。而到2030年，中国的宠物数量将超过7000万只，而四岁以下婴幼儿数量将减少到4000万以下，宠物数量接近婴幼儿数量的两倍。产品端，公司已推出疫苗、驱虫药、保健品等二十余款宠物相关产品，宠物产品研发实力处于国内领先水平，可满足宠物健康养护的多元需求。同时，公司与瑞派宠物医院等战略伙伴深度协同，持续打造一体化宠物生态圈。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200020372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0046","300119","BK0239","159646"],"gpt_icon":0},{"id":"2604162993","title":"瑞普生物：菌丝蛋白项目正按计划推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2604162993","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604162993?lang=zh_cn&edition=full","pubTime":"2026-01-20 15:06","pubTimestamp":1768892776,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物(300119)01月20日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司菌丝蛋白项目的非粮路线是否已与下游饲料/宠物食品企业签订小批量试用协议？试用反馈是否达到预期？非粮路线相关的环保审批、安全认证是否已进入流程？有无明确的节点规划？瑞普生物回复：投资者您好，菌丝蛋白项目正按计划推进中，公司将积极做好产业化和商业化落地，并依据法规法规履行信息披露义务，感谢您的理解与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000018029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300119","BK0239","BK0046","BK0070"],"gpt_icon":0},{"id":"2604166200","title":"瑞普生物：1月19日召开分析师会议，长江证券、上海玄卜投资等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2604166200","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604166200?lang=zh_cn&edition=full","pubTime":"2026-01-20 13:01","pubTimestamp":1768885261,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年1月20日瑞普生物发布公告称公司于2026年1月19日召开分析师会议，长江证券、上海玄卜投资、北京诚盛投资、上海途灵资管、第一创业证券、同泰基金、上海五地私募基金、广东正圆私募、上海保银私募、深圳亘泰投资、睿胜投资、浙江益恒投资参与。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000017311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300119","BK0070","BK0276","BK0239","BK0183","BK0188","BK0046","000783","BK0201"],"gpt_icon":0},{"id":"2603057154","title":"瑞普生物：截至2026年1月9日股东户数25,854户","url":"https://stock-news.laohu8.com/highlight/detail?id=2603057154","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603057154?lang=zh_cn&edition=full","pubTime":"2026-01-13 11:39","pubTimestamp":1768275558,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物(300119)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年1月10日，公司股东数是多少？瑞普生物回复：投资者您好，截至2026年1月9日，公司股东总户数25,854户，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300016366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0070","BK0239","300119"],"gpt_icon":0},{"id":"2602557808","title":"股市必读：瑞普生物（300119）1月9日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2602557808","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602557808?lang=zh_cn&edition=full","pubTime":"2026-01-12 02:08","pubTimestamp":1768154892,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，瑞普生物报收于19.9元，上涨1.12%，换手率1.63%，成交量5.47万手，成交额1.08亿元。董秘最新回复投资者： 请问瑞派宠物在香港IPO上市对于瑞普生物的直接或间接业务影响是什么？请董秘明确一下原料路线，谢谢！公司将严格遵守信息披露相关规定，若后续相关事项达到信息披露标准，将及时通过法定渠道履行披露义务，敬请关注公司公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200000894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0070","300119","BK0239"],"gpt_icon":0},{"id":"2602345947","title":"瑞普生物：深化与瑞派宠物战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2602345947","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602345947?lang=zh_cn&edition=full","pubTime":"2026-01-09 11:36","pubTimestamp":1767929778,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物(300119)01月09日在投资者关系平台上答复投资者关心的问题。投资者提问：请问瑞派宠物在香港IPO上市对于瑞普生物的直接或间接业务影响是什么？瑞普生物回复：投资者您好，感谢您的关注！瑞派宠物医院作为公司参股企业及战略合作方，其香港 IPO 是自身发展的重要举措。公司将持续深化双方在宠物业务上的战略合作，后续若有达到信息披露标准的事项，公司将及时履行信息披露义务，敬请关注公司公告并注意投资风险。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900015213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300119","BK0239","BK0046","BK0070"],"gpt_icon":0},{"id":"2593479866","title":"瑞普生物最新公告：公司及下属公司取得两款新兽药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2593479866","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593479866?lang=zh_cn&edition=full","pubTime":"2025-12-24 18:41","pubTimestamp":1766572871,"startTime":"0","endTime":"0","summary":"瑞普生物公告称，公司及下属公司天津瑞普生物技术股份有限公司空港经济区分公司、瑞普（保定）生物药业有限公司近日获农业农村部批准，取得两款新兽药注册证书。其中，猪圆环病毒2型、猪肺炎支原体、副猪嗜血杆菌三联灭活疫苗为国内技术领先的猪用多联多价疫苗，主要用于预防猪圆环病毒2型感染、猪支原体肺炎及副猪嗜血杆菌血清4型、5型感染引起的疾病。两款产品均有助于提升公司在相关领域的市场占有率和业绩增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400031103.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0070","300119","BK0239"],"gpt_icon":0},{"id":"2593146406","title":"瑞普生物：截至2025年12月19日股东总户数2.5万余户","url":"https://stock-news.laohu8.com/highlight/detail?id=2593146406","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593146406?lang=zh_cn&edition=full","pubTime":"2025-12-23 15:03","pubTimestamp":1766473394,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物(300119)12月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至12月20日，公司持股股东人数多少人？谢谢瑞普生物回复：投资者您好，截至2025年12月19日，公司股东总户数2.5万余户，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300018751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300119","BK0046"],"gpt_icon":0},{"id":"2593483287","title":"瑞派宠物医院递表港交所 为中国第二大宠物医疗服务提供商","url":"https://stock-news.laohu8.com/highlight/detail?id=2593483287","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593483287?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:05","pubTimestamp":1766394300,"startTime":"0","endTime":"0","summary":"据港交所12月22日披露，瑞派宠物医院管理股份有限公司(简称：瑞派宠物医院)向港交所主板递交上市申请，中金公司为独家保荐人。公司简介据招股书，该公司是一家全国性连锁宠物医疗机构，致力 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20251222/c673401584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0046","BK0070","BK0239","300119"],"gpt_icon":0},{"id":"2591261988","title":"瑞普生物（300119）披露董事会换届选举结果，12月16日股价下跌0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591261988","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591261988?lang=zh_cn&edition=full","pubTime":"2025-12-16 17:54","pubTimestamp":1765878859,"startTime":"0","endTime":"0","summary":"截至2025年12月16日收盘，瑞普生物报收于19.03元，较前一交易日下跌0.78%，最新总市值为88.44亿元。该股当日开盘19.21元，最高19.27元，最低18.98元，成交额达7431.76万元，换手率为1.16%。近日，瑞普生物发布2025年第六次临时股东会决议公告，公司于2025年12月15日召开临时股东会，审议通过董事会换届选举议案，选举李守军、徐雷、刘爱玲、朱秀同、李睿为第六届董事会非独立董事，董义春、王凯、李娅为独立董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600030121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300119","BK0046"],"gpt_icon":0},{"id":"2590596808","title":"瑞普生物：截至2025年12月10日股东总户数约2.5万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2590596808","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590596808?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:45","pubTimestamp":1765442739,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物(300119)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至12月10日，公司持股股东人数多少人？谢谢瑞普生物回复：投资者您好，截至2025年12月10日，公司股东总户数约2.5万户，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100025338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0070","300119"],"gpt_icon":0},{"id":"2590831665","title":"瑞普生物：公司无犬肥大细胞瘤mRNA疫苗产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2590831665","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590831665?lang=zh_cn&edition=full","pubTime":"2025-12-09 16:21","pubTimestamp":1765268475,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物(300119)12月09日在投资者关系平台上答复投资者关心的问题。投资者提问：网上流传说：瑞普生物有一款针对犬肥大细胞瘤的MRNA肿瘤疫苗在2024年就已经上市，并于2025年已进入了瑞派、瑞鹏的连锁宠物医院采购体系，这则消息请问是真的 还是 假的？瑞普生物回复：投资者您好，上述相关消息不属实，公司目前无该款产品，相关领域处于研发布局阶段，请以官方公告为准。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900021725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300119","159646","BK0046"],"gpt_icon":0},{"id":"2588725707","title":"瑞普生物（300119）披露召开2025年第六次临时股东会通知，12月1日股价下跌0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588725707","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588725707?lang=zh_cn&edition=full","pubTime":"2025-12-01 17:55","pubTimestamp":1764582928,"startTime":"0","endTime":"0","summary":"截至2025年12月1日收盘，瑞普生物报收于19.83元，较前一交易日下跌0.1%，最新总市值为92.16亿元。该股当日开盘19.85元，最高19.91元，最低19.75元，成交额达5686.71万元，换手率为0.86%。近日，瑞普生物发布公告称，公司将于2025年12月15日召开2025年第六次临时股东会，会议采取现场与网络投票相结合的方式进行，股权登记日为2025年12月8日。公告还指出，中小投资者的表决情况将单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100023679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0070","BK0239","300119"],"gpt_icon":0},{"id":"2586359587","title":"瑞普生物：董事会换届选举","url":"https://stock-news.laohu8.com/highlight/detail?id=2586359587","media":"证券日报 ","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586359587?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:10","pubTimestamp":1764339000,"startTime":"0","endTime":"0","summary":"证券日报网讯 11月28日晚间，瑞普生物发布公告称，公司于2025年11月28日召开第五届董事会第三十次（临时）会议，审议通过了《关于公司董事会换届选举暨提名第六届董事会非独立董事候选人的议案》《关于公司董事会换届选举暨提名第六届董事会独立董事候选人的议案》，董事会提名第六届董事会非独立董事候选人5人：李守军先生、徐雷先生、刘爱玲女士、朱秀同先生、李睿女士；提名独立董事候选人3人：董义春先生、王凯先生、李娅女士。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-28/doc-infyypay7168191.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-28/doc-infyypay7168191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0046","BK0070","300119"],"gpt_icon":0},{"id":"2586382226","title":"瑞普生物（300119）披露取得新兽药注册证书，11月27日股价上涨1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586382226","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586382226?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:35","pubTimestamp":1764254124,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，瑞普生物报收于19.87元，较前一交易日上涨1.07%，最新总市值为92.35亿元。该股当日开盘19.74元，最高20.1元，最低19.62元，成交额达8958.19万元，换手率为1.34%。公司于近日发布公告称，瑞普生物股份有限公司及下属公司近日获得农业农村部核发的猫鼻气管炎、杯状病毒病、泛白细胞减少症三联灭活疫苗新兽药注册证书。产品上市前尚需取得兽药产品批准文号，公司正推进相关申请工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038754.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0070","300119"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770928047283,"stockEarnings":[{"period":"1week","weight":-0.0047},{"period":"1month","weight":-0.0455},{"period":"3month","weight":-0.0999},{"period":"6month","weight":-0.1611},{"period":"1year","weight":0.1689},{"period":"ytd","weight":0.0181}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0011},{"period":"3month","weight":0.036},{"period":"6month","weight":0.1183},{"period":"1year","weight":0.2354},{"period":"ytd","weight":0.0416}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"瑞普生物股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"26214人(较上一季度增加2.53%)","perCapita":"12777股","listingDate":"2010-09-17","address":"天津市东丽区自贸试验区(空港经济区)东九道1号","registeredCapital":"46475万元","survey":"　　瑞普生物股份有限公司的主营业务是兽用生物制品、兽用药物制剂（化学药品、中兽药、消毒剂等）、兽用原料药、兽用功能性添加剂的研发、生产、销售及提供动物疫病整体防治解决方案。公司的主要产品是禽元、优瑞康泰、信法泰、双欣立克、必立清、坦布舒、立本康、康替优、瑞泰净、诸传雄、维乐复康、诸连富、文易舒、倍扶欣、替米佳、依诺佳、瑞必泰、扬极安、必服康、倍汝宁、瑞典康、瑞喵舒、瑞可林、瑞美静、超比欣、莫普欣、菲比欣、妙普净、环舒宁、托曲珠利、头孢噻呋钠、盐酸沃尼妙林。","listedPrice":60},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑞普生物(300119)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑞普生物(300119)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑞普生物,300119,瑞普生物股票,瑞普生物股票老虎,瑞普生物股票老虎国际,瑞普生物行情,瑞普生物股票行情,瑞普生物股价,瑞普生物股市,瑞普生物股票价格,瑞普生物股票交易,瑞普生物股票购买,瑞普生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑞普生物(300119)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑞普生物(300119)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}